Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Debt / NOTE 1.250% 5/1
-
Market price (% of par)
-
95.06%
-
Total 13F principal
-
$410,986,406
-
Principal change
-
-$45,934,346
-
Total reported market value
-
$391,760,463
-
Number of holders
-
61
-
Value change
-
-$44,062,310
-
Number of buys
-
22
-
Number of sells
-
24
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 as of Q3 2024
As of 30 Sep 2024,
BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 was held by
61 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$410,986,406
in principal (par value) of the bond.
The largest 10 bondholders included
MACKAY SHIELDS LLC, Voya Investment Management LLC, Wellesley Asset Management, LAZARD ASSET MANAGEMENT LLC, VICTORY CAPITAL MANAGEMENT INC, Thrivent Financial for Lutherans, JPMORGAN CHASE & CO, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, Jefferies Financial Group Inc., and STATE STREET CORP.
This page lists
61
institutional bondholders reporting positions
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.